Temporal lobe epilepsy (TLE) is the most common focal epilepsy in adults. TLE has a high chance of becoming medically refractory, and as such, is frequently considered for further evaluation and surgical intervention. Up to 30% of TLE cases, however, can have normal ("nonlesional" or negative) magnetic resonance imaging (MRI) results, which complicates the presurgical workup and has been associated with worse surgical outcomes. Helped by contributions from advanced imaging techniques and electrical source localization, the number of surgeries performed on MRI-negative TLE has increased over the last decade. Thereby new epidemiologic, clinical, electrophysiologic, neuropathologic, and surgical data of MRI-negative TLE has emerged, showing characteristics that are distinct from those of lesional TLE. This review article summarizes what we know today about MRI-negative TLE, and discusses the comprehensive assessment of patients with MRI-negative TLE in a structured and systematic approach. It also includes a concise description of the most recent developments in structural and functional imaging, and highlights postprocessing imaging techniques that have been shown to add localization value in MRI-negative epilepsies. We evaluate surgical outcomes of MRI-negative TLE, identify prognostic makers of postoperative seizure freedom, and discuss strategies for optimizing the selection of surgical candidates in this group. KEY WORDS: Semiology in temporal lobe epilepsy, TLE with normal MRI, FDG-PET-positive TLE, Surgical outcomes in TLE, Epileptogenic network in TLE, Histopathology TLE.
• Electroclinical and quantitative imaging studies suggest involvement of different epileptogenic networks in MRI-negative TLE compared to mesial TLE with HS on MRI (HS + MTLE)
• Pooled rate of postsurgical seizure freedom in patients with MRI-negative TLE is 51% compared to 75% in HS + MTLE
• However, surgical outcomes in MRI-negative TLE with concordant electroclinical findings and temporal PET hypometabolism are excellent and similar to HS + MTLE
• In patients with negative/discordant functional imaging, intracranial EEG remains important for identifying temporal-plus or pseudotemporal epilepsy syndromes Temporal lobe epilepsy (TLE) represents the most prevalent form of localization-related epilepsies, especially in tertiary referral centers, 1 where many of these cases have demonstrated pharmacoresistance and are potential candidates for epilepsy surgery.
Hippocampal sclerosis (HS) is the most common pathology identified on magnetic resonance imaging (MRI) of patients treated with anterior temporal lobectomy (ATL) for drug-resistant TLE. Other pathologic MRI findings include tumors, vascular malformations, malformations of cortical development, and evidence of remote trauma, postinfectious, or ischemic damage. Roughly 30% of patients with electroclinical evidence of drug-resistant TLE, however, have normal MRI scans on visual inspection (MRI-negative TLE). 2 This causes inherent difficulty in identifying the epileptogenic zone in these patients. Yet with improved localization techniques, these cases often remain amenable to surgical resection.
Some physicians regard MRI-negative TLE as lying within the same spectrum as mesial TLE (MTLE) with HS (HS + MTLE), whereas others opine that MRI-negative TLE exists as a distinct entity. [3] [4] [5] In this review, we summarize the literature on MRI-negative TLE and critically appraise electroclinical and imaging studies that compare MRI-negative TLE with HS + MTLE. We also aim to examine surgical outcomes in MRI-negative TLE patients, answering these increasingly relevant and pressing questions: How can we best optimize the selection of MRI-negative TLE patients who undergo epilepsy surgery? Can we select a group of MRI-negative TLE patients who do not need to undergo invasive intracranial EEG (ICEEG) monitoring preoperatively?
The Changing Landscape of MRI-negative TLE
In this article, we define "MRI-negative TLE" to represent a disorder where recurrent unprovoked seizures occur with or without secondary generalization, originating from the temporal lobe based on electroclinical findings, in the absence of an epileptogenic lesion on visual inspection of the MRI. Seizures may originate from the mesial or lateral temporal regions (or simultaneously from both), sometimes with variable extension of the epileptogenic zone (EZ) to include the neighboring lobes ("temporal-plus" epilepsy).
In reality, what constitutes MRI-negative TLE continues to evolve due to the advent of advanced imaging techniques. Increased use of high magnetic field epilepsy-protocol 3T (Tesla) MRI scans has pushed many of what used to be considered MRI-negative TLE cases into the lesion-positive group, resulting in increased detection of HS, focal cortical dysplasia (FCD), and dysembryoplastic neuroepithelial tumors (DNET). 6 Small temporal pole encephaloceles are now recognized for being a hidden cause of "MRI-negative" TLE. 7 Furthermore, cases of TLE with ipsilateral amygdala enlargement have recently gained recognition for being a possible subtype of MRI-negative TLE.
MRI quantification of hippocampal volume and T2 signal has also improved the sensitivity for detecting HS. Automated volumetry and relaxometry analysis have independently demonstrated hippocampal atrophy and hyperintense T2 signal relating to hippocampal gliosis in 13% and 19% of patients with visually normal MRI findings, respectively. 8 In fact, in vivo multi-parametric MRI using volumetry, T2 signal, quantitative T1 mapping, and diffusion MRI parameters have been correlated with histologic features of HS in a subfield-specific manner, and can now predict neuronal loss with up to 90% accuracy. 9 With increasing acceptance of quantitative MR studies into clinical use, the entity of MRI-negative TLE may become more homogeneous and better characterized over time.
Epidemiology and Disease Course
Few large-scale, community-based epidemiology studies in TLE exist. The prevalence of TLE in Rochester, Minnesota (1960) , was estimated at 1.7 per 1,000 people. 10 In a separate population-based study, TLE constituted 9% of all patients with epilepsy, and 21% of those with localization-related epilepsy. 11 These numbers were based on the electroclinical presentation of TLE and did not include imaging techniques as an additional diagnostic feature, so the true ratio of MRI-negative TLE cases in the general population remains unknown. Among tertiary care centers, however, the prevalence of TLE has been well studied and averages about 66% of cases of localization-related epilepsy. 1, 12 About 30% of that patient cohort are MRI negative.
Although TLE in general has a high propensity to develop drug-resistance (up to 71%), 13 it is possible that patients who are MRI negative may have a milder disease course compared to their HS + MTLE counterparts. 14 In one longitudinal study on MRI-negative TLE, 43 (59%) of 73 patients had mild TLE (seizure-free for at least 3 years, or had ≤2 seizures per year for at least 3 years). 15 Another study reported a good response to anticonvulsant drugs (with a mean seizure-free period of 4.3 years on just 1 or 2 compared to 2 or 3 drugs) in about 55% of their MRI-negative TLE cohort. Clinical features associated with a better drug response include an older age at onset, a lower rate of initial precipitating events (i.e., febrile seizures, central nervous system [CNS] infections or head trauma), as well as a lower prevalence of electroencephalography (EEG) abnormalities, antecedent auras, automatisms, and secondarily generalized seizures. 16 Similarly, a good response to the first antiepileptic drug has been associated with a mild course of TLE. 13 Both studies specifically excluded familial cases of TLE, which also tend to be associated with an onset in late adolescence or early adulthood, rather than childhood, a benign course in up to 40% of the cases, and a nonlesional MRI in 40-60% of the cases. 17 
Clinical Demographics and Risk Factors
Several small-to moderate-scale retrospective studies 3, 4, 18 exist comparing the clinical profiles of MRI-negative TLE with HS + MTLE, and their findings are summarized (Table 1 ). These studies suggest that patients with MRI-negative TLE are less likely to have a prior history of febrile seizures, tend to have a later age at seizure onset/shorter duration of epilepsy until surgery, and have a greater tendency for secondary generalization of seizures. The latter has been found to be associated with an up to 10.8-fold increased risk for seizure recurrence following surgical resection in the MRI-negative TLE cohort. 19 This may reflect an epileptogenic network where ictal spread and secondary generalization occur more efficiently, or it may indicate a brain with an overall lower epileptogenic threshold in MRI-negative TLE that appears to be distinctive from HS + MTLE. However, the small sample size of the MRInegative cohorts has frequently precluded a meaningful statistical comparison. Furthermore, the patients in these studies underwent 1.5T MRI scans. It is possible that the demographics of MRI-negative TLE patients will be different today when selected based on higher-field MR imaging.
Seizure Semiology
Auras can have useful localization value in MRI-negative TLE, and may help to identify seizures with mesial or lateral temporal onset. Simple auditory auras in the form of ringing or buzzing noises point to the primary auditory cortex within Heschl's gyrus, whereas complex auditory phenomena, such as music or voices, suggest involvement of the auditory association area in the temporooccipital cortex. Vertiginous auras may be formed from the posterior temporal region, especially at the temporoparietooccipital (TPO) junction, 20, 21 whereas complex visual hallucinations and tunnel vision may originate from either the temporooccipital or anteromedial/basal temporal lobe structures. 22 Abdominal and olfactory auras occur predominantly in mesial TLE, although olfactory auras may also occur in seizures originating from orbitofrontal cortex. 23 Gustatory auras may be a manifestation of either parietal operculum or basal temporal cortex seizures. 24 Psychic auras such as fear, d ej a-vu, or jamais-vu are closely related to temporal lobe localization, and are more common in mesial than in lateral TLE. 25 The relative incidence of auras by spatial distribution is summarized in Table 2 .
It is not easy to distinguish between mesial and lateral temporal onset seizures based on ictal manifestations, 26 although a few studies suggest variable association of oroalimentary and limb automatisms, longer seizure duration, and absent or rare secondary generalizations with mesial temporal over lateral temporal onset seizures. 27, 28 MRI-negative TLE may also include the cohort of temporal-plus epilepsies. Temporal-plus epilepsies refer to seizures of multilobar origin involving the temporal lobe and closely associated structures such as the orbitofrontal cortex, insula, frontal/parietal operculum, and temporoparietooccipital junction. Chances of achieving seizure freedom from standard ATL or selective amygdalohippocampectomy (SAH) are lower in these cases. 29, 30 Thus it is useful to be able to distinguish temporal lobe from temporal-plus epilepsies. Patients with TLEs are more frequently able to give a warning at seizure onset, manifest with an abdominal aura, and develop gestural automatisms and a postictal amnesia. Conversely, patients with temporal-plus epilepsies have gustatory, vertiginous, and auditory symptoms more frequently. 31 
Electrophysiologic Studies: Scalp and Intracranial EEG (ICEEG) Recordings
Scalp EEG in MRI-negative TLE About 2-3% of patients with refractory TLE have absent or rare (<1/h) interictal epileptiform discharges (IEDs) on serial scalp EEGs, and are termed "oligospikers." Patients with MRI-negative TLE with refractory disease who are "oligospikers" nonetheless seem to have less severe disease compared to their "frequent spikers" counterparts; they have a lower monthly frequency of complex partial seizures as well as a lower incidence of secondarily generalized seizures and status epilepticus. 32 Surgical outcomes in both groups are comparable. Patients with MRI-negative TLE with strictly unilateral IEDs have been shown to have better surgical outcomes compared to those with bilateral independent discharges. 33, 34 Those with unilateral anterior temporal IEDs also perform better than those with posterior temporal, bilateral temporal, or generalized IEDs. 35, 36 Other studies have shown a correlation between a welllocalized scalp ictal EEG pattern with rhythmic temporal theta discharges at onset, with better postoperative seizure control regardless of IED findings. [37] [38] [39] This initial pattern of ictal discharge (Ebersole type I pattern) has been associated with hippocampal-onset seizures, whereas lateralized irregular delta slowing (Ebersole type II) and nonlateralized discharges (Ebersole type III) have been associated with seizures of lateral temporal origin, which in turn have less favorable outcomes with standard ATL. 40 The median frequency of initial ictal discharge appears to be directly correlated with the degree of HS, 41 and it has been observed that MRI-negative TLE patients more commonly have a delta rhythm (Ebersole type II) at ictal onset when compared with HS + MTLE patients, 5 suggesting that a higher percentage of MRI-negative TLE cases have seizure onset in the lateral temporal cortex.
The caveat guarding against an overreliance on ictal scalp EEG patterns for localization, is that an Ebersole type I pattern can also be seen in pseudotemporal (so called TLE mimics) epilepsy, indicating that this rhythmic theta pattern can be a result of propagation from extratemporal regions. 42 On the other hand, atypical or nonlocalizing scalp EEG findings may very well demonstrate mesial temporal seizure onset on ICEEG, 43 again reiterating the limited reliability of electroclinical localization in TLE.
Instead, the localizing value of scalp EEG may be further enhanced by the use of electrical source imaging (ESI). ESI is a technique that applies source localization algorithms (inverse models) to estimate the spike source generators from scalp EEG recordings, and may be a valuable tool for analyzing patients with MRI-negative epilepsies. Modeling of IEDs using dense array scalp EEG (up to 256 channels) have been shown to localize the seizure-onset zone in up to 44 It must be remembered, however, that both the sensitivity and specificity of ESI will drop with a lower number of electrodes (such as that used in a conventional scalp EEG with <32 channels), or with the use of a template head model (instead of using the patient's own MRI as the head model). 45 
Intracranial EEG in MRI-negative TLE
The main incentives for performing ICEEG in MRI-negative TLE are the following: (1) exclusion of bitemporal, pseudotemporal, or temporal-plus epilepsies, all of which lead to less favorable surgical outcomes with standard ATL; and (2) exploring the possibility of a hippocampal-sparing procedure should the hippocampus not be involved in seizure generation, in order to reduce the risk of postoperative verbal memory decline, a risk of particular concern when operating on the dominant hemisphere. 46 A number of anatomically deep and semiologically silent areas can produce seizures that are clinically and electrophysiologically indistinguishable from MTLE (TLE mimics), including the temporal pole, orbitofrontal cortex, insula, cingulate, and TPO (giving rise to pseudotemporal epilepsy). Hence, due consideration should be given to coverage of these regions during ICEEG planning.
Studies analyzing ICEEG recordings in MRI-negative TLE patients have revealed seizures arising exclusively from mesial temporal structures (38-72%), lateral temporal cortex (11-25%), simultaneously from mesial and lateral temporal lobe (22-25%), and independently from mesial and lateral temporal lobe (16-17%). [47] [48] [49] Examples demonstrating the heterogeneity of seizure-onset zones in MRInegative TLE as recorded by ICEEG are shown in Figure 1A -C.
ICEEG also plays an important role in providing guidance for epilepsy surgery in patients with ambiguous or presumed bilateral temporal epilepsy (BiTLE) on scalp EEG. A recent systematic review (n = 1,403 patients) found that a substantial proportion of these patients (73%) turned out to have unilateral TLE on ICEEG evaluation. In the subgroup analysis, 63% of the patients with normal MRI and unilateral TLE on ICEEG had Engel I outcomes at 1 year follow-up. 50 Therefore, surgery should not be excluded based on scalp EEG findings alone. Even in patients with ICEEG-confirmed BiTLE, a palliative temporal lobectomy -if chosen wisely-can provide substantially improved seizure control in up to 45-51% of patients, as well as an improved quality of life. 51 Thereby factors that should determine the side of the resection in these cases are the onset zone of the most debilitating seizures, lateralizing findings on MRI and positron emission tomography (PET), as well as memory deficits during Wada testing lateralizing to the side of the surgery. The lateralization of the seizure count on the other hand is a controversial predictor for good surgical outcome, as the number of seizures recorded might have either been too low or there might have been a false lateralization due to clustering of seizures.
Intraoperative electrocorticography (ECoG) is also often used to guide resection of epileptogenic tissue. Patients with MRI-negative TLE may be more likely to have a better surgical outcome if complete resection of their baseline ECoG IEDs is achieved. 33 Intraoperative ECoG may also be useful in identifying a subset of patients with MRI-negative TLE who do not need chronic implantation of electrodes prior to standard ATL. These patients have large, frequent interictal spikes arising from the mesial temporal structures (hippocampus, parahippocampal gyrus, or temporal tip) without involving other locations, and have surgical outcomes comparable to patients who have HS + MTLE. 47 
Structural Imaging-MRI and DTI Studies
Although MRI-negative TLE does not appear to have a visible epileptogenic lesion on visual analysis, structural alterations have been detected using quantitative measurements when performing group comparisons between MRInegative TLE, HS + MTLE and healthy controls. In this way, structural MRI covariance analysis and diffusion tensor imaging (DTI) have both been used to draw inferences about structural networks in different subtypes of TLE. The mechanisms that underlie progressive structural damage in TLE remain unknown, but hypotheses include excitotoxic effects from recurrent seizure activity or deafferentation secondary to neuronal loss.
MRI
Patterns of structural covariance may be measured using gray matter volumes or cortical thickness, using voxelbased and surface-based morphometry, respectively, for group-level analysis. Multiple studies have compared patterns of gray matter atrophy between MRI-negative TLE and HS + MTLE.
Initial studies using "volume of interest" analyses described volumetric abnormalities not just in the ipsilateral hippocampus, but also in the amygdala, entorhinal, perirhinal, and temporopolar cortices in HS + MTLE. [52] [53] [54] [55] Meanwhile in MRI-negative TLE, entorhinal cortex atrophy was found ipsilateral to the seizure focus. 56 The subsequent use of optimized voxel-based morphometry (VBM) allowed for increased sensitivity to whole-brain changes, and demonstrated widespread patterns of gray matter atrophy in both HS + MTLE as well as MRI-negative TLE patients. In HS + MTLE, decreased gray matter volume beyond the hippocampus could be found in the thalamus, insula, putamen, parahippocampal gyrus, superior temporal gyrus, frontal regions, postcentral gyrus, cerebellum, and cingulum. In MRI-negative TLE, despite not having any volumetric loss in the hippocampus, decreased gray matter volume was also variably found in the thalamus, insula, parahippocampal gyrus, superior and inferior temporal gyri, frontal and orbitofrontal cortices, postcentral gyrus, cerebellum, and cingulum. 57, 58 These overlapping and yet distinctive patterns of widespread temporal and extratemporal cortical thinning (Fig. 2) have been corroborated using surface-based morphometry in both HS + MTLE as well as MRI-negative TLE patients. 58, 59 Such patterns are not obvious from visual inspection of the MRI data.
A special mention should be given to the subset of MRInegative TLE with ipsilateral amygdala enlargement (AE). Volumetric MRI studies performed on MRI-negative TLE have detected statistically significant AE in 12-16% of MRI-negative TLE patients. 60, 61 This group is still undergoing characterization, and its etiology remains uncertain, but these patients seem to have a more benign course (with 50% achieving seizure freedom with drug therapy), and some have partial or full remission of AE on MRI follow-up. 62 Aggregated hypertrophic neurons with slight gliosis/without gliosis seem to be a pathologic characteristic of AE. 63 
DTI
Diffusion tensor imaging provides an indirect assessment of white matter integrity, and is more sensitive than conventional MRI in detecting white matter abnormalities. The two most frequently measured DTI metrics are mean diffusivity (MD) and fractional anisotropy (FA), describing magnitude and preferred directionality of water diffusion within each voxel.
Voxel-wise statistics have confirmed the presence of microstructural white matter changes in patients with MRI- . Patients A and C underwent a standard ATL and patient B had a responsive neurostimulator (RNS) placed with strips covering the epileptogenic zone. All three patients had Engel class I outcomes at their last 6-month follow-up visit. Epilepsia ILAE negative TLE, revealing significant FA reductions in the corpus callosum, bilateral superior and inferior longitudinal fasciculi, and left corticospinal tract (CST). MD increases have also been observed in the left superior longitudinal fasciculus and left CST. 64 DTI abnormalities have been reported to be more pronounced and widespread in patients with HS + MTLE compared with patients with MRI-negative TLE, a finding observed using tract-based spatial statistics (TBSS) 58 as well as tractography analysis. 65, 66 For example, although widespread and bilateral reductions of FA do occur in MRI-negative TLE, some fornix and cingulum DTI abnormalities appear to be seen exclusively in HS + MTLE. This finding has also been used to support the presence of different dysfunctional networks in both disorders.
Functional Imaging-fMRI, MRS, PET, and SPECT
Functional MRI (fMRI)
In addition to morphologic alterations, there is mounting evidence that MRI-negative TLE and HS + MTLE show different patterns of functional network and brain changes. Voxel-resolution graph theoretical analysis applied to task-free functional MRI (fMRI) data in MRInegative TLE demonstrated decreased connectivity at the ipsilateral temporal neocortex with relative sparing of mesial temporal structures in one study, as opposed to increased connectivity seen within the affected mesial temporal lobe and anterior thalamus, and decreased connectivity from sclerotic hippocampus to the contralateral temporal lobe and regions of the default mode network in HS + MTLE. 67 In the first investigation of its kind to correlate resting-state functional network alterations to structural pathology, Bernhardt et al. 66 also showed marked hippocampal decoupling from anterior and posterior default mode hubs in HS + MTLE, whereas patients showing isolated gliosis on pathology (many of whom had normal MRI results) did not differ from controls. Using a different approach and measuring spontaneous brain activity from single voxels or demarcated regions directly, the fractional amplitude of low-frequency fluctuations (fALFFs) in the blood oxygen level-dependent resting-state fMRI signal (used as a marker of local metabolic demand at rest) has been found to be reduced in the ipsilateral amygdala and hippocampus in HS + MTLE, and marginally reduced in the ipsilateral amygdala but not hippocampus in MRI-negative TLE. 68 
MRS
Proton magnetic resonance spectroscopy ( 1 H-MRS) has played an important role in detecting metabolic alterations in patients with TLE, although its popularity lags behind PET and single photon emission computed tomography (SPECT) in the presurgical evaluation of MRI-negative TLE. N-Acetyl aspartate (NAA) is synthesized only in neuronal mitochondria, and a relatively higher concentration of creatine is found in astrocytes. Reduction of NAA signal is believed to be associated with neuronal loss or dysfunction, whereas an increase in creatine (Cr) signal suggests gliosis. Hence studies tend to use the NAA/Cr ratio as a marker of neuronal function of the neuronalglial unit. Perhaps more importantly, the NAA/Cr alterations picked up by MRS imaging (MRSI) have been shown to reflect neuronal and glial dysfunction rather than neuronal cell loss, 69, 70 making this marker relatively independent of tissue atrophy. Reduced levels of NAA/Cr or NAA/Cr+Choline (Cho) in patients with TLE have been found beyond the ipsilateral hippocampus, involving regions such as the thalami, insula, frontal lobes, parietal lobes, and contralateral hippocampus. [71] [72] [73] A few small-scale MRS studies have also been published on patients with MRI-negative TLE. Most of these are single-voxel spectroscopy (SVS) studies, with voxels of interest placed bilaterally either in the hippocampi or temporal lobes. Connelly et al. 74 was one of the first to describe a reduced NAA/Cho+Cr ratio over the ipsilateral mesial temporal lobe in five of seven patients with MRInegative TLE, two of whom had bilaterally low ratios. Subsequent studies demonstrated similarly reduced NAA/ Cr ratios or reduced NAA levels in the hippocampus ipsilateral to the seizure focus, also with a small proportion having bilateral findings. [75] [76] [77] When compared to HS + MTLE, metabolic dysfunctions in the hippocampi in MRI-negative TLE were less commonly detected, and were milder when present. Mueller et al. 78 used MRSI in the comparison of HS + MTLE and MRI-negative TLE, which provided spectroscopic information from the whole brain. It demonstrated low NAA/(Cr+Cho) ratios in both groups, in ipsilateral as well as contralateral temporal and extratemporal regions. A high degree of interindividual heterogeneity and variability of the metabolic abnormalities within each of the two groups prevented the identification of distinct group patterns.
Other metabolites may soon be given the spotlight. cAminobutyric acid (GABA) and glutamate are the major excitatory and inhibitory neurotransmitters in the brain, respectively. The availability of ultra-high-field 7T MRI scanners, with their increased signal-to-noise ratio and increased spectral resolution, will allow GABA and glutamate concentrations to be measured, which may offer insights into their roles in epileptogenesis in the near future.
PET
PET scans utilizing 2-[ 18 F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) and other ligands can help identify epilepsy-related metabolic disturbances when MRI is negative. The underlying pathophysiologic basis for the reduction in glucose uptake (relative focal or regional hypometabolism) seen in the interictal state is still unresolved. Electroclinical studies suggest that the pattern of hypometabolism may relate to both the onset of the ictal discharge and the patterns of preferential spread, 79 representing a dysfunctional neural network. Because FDG-PET usually shows an area of hypometabolism extending beyond the EZ, it cannot be used to delineate the surgical margins, but it nevertheless remains useful for lateralization and general localization of epilepsy.
In a 2008, meta-analysis of the contribution of FDG-PET in preoperative evaluation for patients with TLE, PET hypometabolism concordant with the side of surgery was identified in 76.8% of MRI-negative TLE and had a positive predictive value for good outcome (defined as Engel class I and II) in 80%, even though analyses was complicated by significant differences in study design and often by lack of precise patient data. 80 Several other studies, however, have supported the finding that ipsilateral FDG-PET hypometabolism is a positive predictor for seizure-free outcome following standard ATL. 5, 81 In one study, an odds ratio of 7.1 was reported for FDG-PET in predicting a seizure-free outcome. 82 A handful of small observational studies have compared FDG-PET findings between patients with MRI-negative TLE and age-and sex-matched HS + MTLE, looking at sublobar patterns of PET hypometabolism using semi-quantitative analyses. 5, 83 They have identified several distinct differences between the two groups: HS + MTLE has greater hypometabolism in mesial temporal/hippocampal regions, whereas MRI-negative TLE has greater inferolateral temporal involvement. Moreover in MRI-negative TLE, the area of hypometabolism frequently extends beyond the mesial and anterior temporal structures affecting the posterior temporal and even extratemporal regions. This finding might suggest a more extensive epileptogenic network in MRI-negative TLE compared to HS + MTLE. Of interest, neither the mesial nor the extramesial hypometabolism in the MRI-negative group appears to correlate with any neuropathologic changes of the hippocampal structures. Even the rate of focal cortical dysplasias (FCDs) is not significantly different. 81, 83, 84 So neither the degree of neuronal loss nor presence of dysplasias can explain the increased extent of PET hypometabolism. This raises the concern that the PET hypometabolism represents a more diffuse epileptogenic network in MRI-negative TLE patients. At the same time, it also emphasizes a need to gain at least some understanding of the actual cause(s) of relative hypometabolism depicted by FDG-PET, a gap in knowledge that remains despite the presence of this technology and the above observations found in patients with focal epilepsy for nearly four decades.
Other PET tracers besides FDG may be useful in the evaluation of MRI-negative TLE. These include [
11 C] flumazenil (FMZ), which shows decreased GABA A receptor binding in the presumed epileptic focus, demonstrating a more restricted region of hypometabolism compared with FDG-PET; 85 and [ 11 C] alpha-methyl-tryptophan (AMT), a marker of increased and/or aberrant serotonin (5-HT) metabolism, showing areas of increased AMT uptake corresponding to the EZ. 86 However, the lack of commercial availability of these radiotracers and the short half-life of 11 C effectively preclude their use in routine clinical practice without an on-site cyclotron. In addition, further validation of their diagnostic accuracy is warranted.
SPECT
Both 99m Tc-hexamethylpropyleneamine oxime ( 99m Tc-HMPAO) SPECT and 99m Tc-ethyl cysteinate dimer ( 99m Tc-ECD) provide an indirect measurement of cerebral blood flow (CBF) changes, and are performed in both interictal and ictal states for preoperative seizure localization. SPECT is based on the assumption that increased ictal neuronal activity leads to increased regional CBF and hence an increased tracer uptake in the EZ. Conversely, typical interictal SPECT should show the EZ as a low perfusion region and hence a hypoactive focal area. Ictal hyperperfusion switches to hypoperfusion during the early postictal state, to a degree less marked than that seen in interictal perfusion. Subtraction ictal SPECT coregistered to MRI (SISCOM) has been shown to improve localization of the EZ, 87, 88 and concordant localization of the hyperperfusion focus in SIS-COM to the resection site is associated with improved surgical outcomes. 36, 89 Statistical comparisons with normative data have also been recently incorporated into SPECT studies, namely ictal-interictal SPECT analyzed by statistical parametric mapping (ISAS) 90 and statistical ictal SPECT coregistered to MRI (STATISCOM). A recent study comparing different SPECT post-processing methods in MRI-negative TLE demonstrated 38%, 67%, and 71% co-localization with resection sites using SISCOM, ISAS, and STATISCOM, respectively. 91 In this study, localization of the hyperperfusion focus in ISAS and STATISCOM to the surgical site was associated with an excellent surgical outcome (as defined by remaining seizure-free or having only nondisabling seizures with a minimum period of 1 year post-surgical follow-up), but not in SISCOM. The authors however acknowledged that their SISCOM concordance to the resection site was lower than expected; another study had demonstrated concordance rates as high as 81.8%. 36 A separate study showed the superiority of STATISCOM over SISCOM by demonstrating an 80% versus 47% correct localization of the TLE subtype (mesial vs. lateral) in MRI-negative TLE, 92 using ICEEG as a reference marker. No matter the postprocessing method, the timing of the SPECT radiotracer injection is crucial, and there is always a possibility of false localization/lateralization due to ictal propagation, especially with late injections.
It should be emphasized that FDG-PET and SPECT have complementary roles, as patients may have positive findings on one modality but not the other, and each modality can be used as an independent predictor of seizure-free outcomes after surgery. 82 
Histopathology
The review and comparison of histopathologic results between studies on MRI-negative TLE cases is very challenging in multiple ways. Frequently the pathologic diagnosis is based on the read of a single neuropathologist who may be biased by the patient's electroclinical and imaging findings, and at times the criteria used for the pathologic classification are missing in publications. Other than in standardized ATLs, the tissue samples resected and used for the pathology review can vary quite significantly in quality, processing step, and tissue location (i.e., bias toward mesial temporal vs. lateral temporal vs. temporal pole structures).
Moreover it has been difficult to define a practical classification system for hippocampal pathology that would result in a good interrater reliability, even among well-experienced neuropathologists from globally established institutions. 93 Despite these restrictions, the spectrum of histopathology findings in MRI-negative TLE surgical outcome studies reveals the heterogeneity of this group: The majority of the studies include histopathology from standard ATLs and show that the most common histopathologic diagnoses are either "no evidence of HS at all" (i.e., a histologically normal hippocampus) or nonspecific gliosis, followed by HS. This seems to hold true for studies using 1.5T and 3T MRI in their selection of MRI-negative cases. 19, 33, 35, 36, 38, 94, 95 Of interest, FCDs appear to be more common in studies that do either a selective review or resection of the temporal pole or lateral temporal lobe (Table 3) . 48, 49, 96 This raises the question of whether studies with available ATL histopathology are biased toward the analysis of mesial temporal structures and are actually undersampling the temporal pole and lateral temporal neocortex, thereby missing out on a higher rate of dual pathology in the MRI-negative TLE patient cohort.
As mentioned before, a significant proportion of MRInegative TLE cases demonstrate no significant neuronal cell loss but gliotic changes of the hippocampus only on histopathology (so called "TLE-G"). This falls under the "no-HS, gliosis only" group in the 2013 International League Against Epilepsy (ILAE) consensus classification of HS, in which only about 30% may have subtle increases in hippocampal T2 signal intensity on MRI. 66 Focal increases in T2 and MD have been largely restricted to the subiculum, which, as the major output for the hippocampal subfields, supports its key role in propagating hippocampal generated seizures. As such it might be one of the first structures to show histologic and/or imaging abnormalities related to recurrent seizure activity, and might function as a target for specific imaging analysis.
To date, even studies with a reasonable sample size have not been able to identify any particular histopathologic diagnosis as a positive predictor for good postsurgical (seizurefree) outcome in MRI-negative TLE. In fact some of the studies have shown that 40-50% of MRI-negative TLE patients with a histopathology diagnosis of HS remain with seizures after resective surgery. 33, 36, 38 Although there is a 2.85 odds ratio of having a seizure-free outcome if a positive pathology is identified on the resected specimen, 97 finding a negative pathology (defined by finding of gliosis only, or no microscopic tissue anomaly identified), nevertheless, does not preclude seizure freedom.
Surgical Outcomes and Predictors
Surgical outcomes in MRI-negative TLE Past studies have consistently shown poorer surgical outcomes in MRI-negative TLE, compared with HS + MTLE. 98, 99 This may result from a combination of factors, such as the presence of an intrinsically more widespread epileptogenic network in MRI-negative TLE, inadequate EZ resections (e.g., selective amygdalohippocampectomy performed in cases with entorhinal and temporal pole involvement, or inclusion of temporal-plus epilepsy), or presurgical false localization error. In a recent meta-analysis, 97 the pooled proportion of seizure-free patients in MRI-negative TLE was 51% (95% confidence interval [CI] 45-57) compared with 75% (95% CI 71-89) in HS + MTLE. Additional observational studies reporting surgical outcomes in MRI-negative TLE patients have documented 41-81% Engel I outcomes at 1 year (Table 3) . The wide variation in surgical outcomes likely reflects the broad heterogeneity in the study population, including the likelihood of localization error in a proportion of these patients.
However, despite the less favorable postsurgical outcomes reported, several recent studies have shown that it remains possible to achieve excellent surgical outcomes in carefully selected patients within the MRI-negative TLE population. Specifically, the presence of relative focal temporal lobe hypometabolism demonstrated on FDG-PET ipsilateral to the EEG side of seizure-onset is associated with Engel class I postoperative outcomes in 75-80% of MRI-negative TLE, closely matching the 71-82% surgical seizure-freedom rates seen in HS + MTLE. 5, 81, 96, [100] [101] [102] Surgical outcome predictors in MRI-negative TLE Several studies have looked into the surgical outcome predictors in MRI-negative TLE (Table 3) . Good prognostic factors on univariate analyses include an antecedent history of febrile seizures, shorter duration of epilepsy, later age at onset of seizures, an absence of contralateral or extratemporal interictal epileptiform discharges, Ebersole type I ictal EEG pattern, presence of subtle nonspecific MRI findings in mesial temporal lobe concordant to resection side, and concordance of SISCOM hyperperfusion focus to resection site. Bad prognostic factors identified include a higher baseline seizure frequency and the presence of generalized tonic-clonic (GTC) seizures. A recent meta-analysis of surgical prognostic factors in MRI-negative TLE found a shorter epilepsy duration (<20 years until surgery) and ictal/interictal EEG discharges localized to the ipsilateral temporal lobe to be significantly correlated with seizurefree outcomes after surgery. 103 The limitations of the above studies include their small sample sizes and retrospective designs with inherent missing data variables and misclassification bias. The heterogeneity of the study data is a major drawback, with lack of standardized imaging protocols, variable use of ICEEG monitoring (temporal-plus or pseudotemporal epilepsies could have been included), different surgical margins and techniques, variable duration of follow-up, and different seizure-freedom outcome measures. In addition, as most of the study subjects underwent 1.5T MRI scans, a proportion of the "MRI-negative" cases may be labeled lesion-positive on 3T MRI imaging today.
Conclusion and Future Directions
One of the biggest challenges with studying the MRInegative TLE patient population is that correct classification depends almost exclusively on the quality/resolution of the MRI and a provider's expertise in interpreting those images. To reduce the chance of lesional epilepsies being misclassified as "MRI-negative TLE," we have included only studies that used either 1.5T or 3T MRIs in this review.
Most of the literature available on MRI-negative TLE, and those comparing and contrasting this group with HS + MTLE patients, are retrospective observational studies. Nonetheless, there is evidence of electroclinical and imaging differences between the MRI-negative TLE and HS + MTLE cohorts, supporting the notion that these are distinct syndromes with possibly different pathophysiologies and epilepsy networks (Table 4) . MRInegative TLE does not appear to be just an early "HSvariant." In fact it appears to be a heterogenous group encompassing mesial-and lateral-temporal onset epilepsies, as well as temporal-plus epilepsies, with greater variation in histopathology and surgical outcomes. We acknowledge that within this diverse group, undoubtedly there will be a subset that contains those with mild HS not picked up on MRI, as the qualitative studies we have evaluated mostly did not perform hippocampal volumetry or other quantitative measures when selecting MRI-negative TLE study subjects. MRI-negative TLE surgical outcomes remain poorer compared with HS + MTLE, which is probably in part contributed by false localization due to the absence of a visible epileptogenic substrate, or SAH or standard ATL performed for lateral or temporal-plus cases. Yet, with careful selection of candidates such as those with ipsilateral FDG-PET temporal hypometabolism and electro-clinical concordance, it is possible to achieve excellent surgical outcomes that match those with HS + MTLE. The option of surgery should certainly not be denied to this subgroup of patients, and an FDG-PET scan should become an established part of a routine presurgical workup of patients with MRI-negative TLE.
Many patients with MRI-negative TLE will undergo ICEEG monitoring as part of their presurgical workup. However, this invasive process carries a certain degree of risks, including infection, hemorrhage, and stroke; it also requires high-level expertise, and incurs additional costs.
There are two groups of MRI-negative TLE patients in whom ICEEG plays an important role. First, in those with dominant side TLE, the hippocampus may be spared during surgery if ICEEG proves the absence of its involvement, with the benefit of preserving verbal memory. Second, in those with negative/discordant functional imaging (FDG-PET/SPECT), or those with atypical electroclinical findings (e.g., interictal spikes with maximum negativity over the mid/posterior temporal region), ICEEG may help to identify temporal-plus epilepsy or pseudotemporal epilepsy syndromes, leading to more extensive tailored surgical resections, or completely different resections than SAH or ATL. Just as important, ICEEG can provide guidance for epilepsy surgery in MRI-negative TLE patients with ambiguous or presumed BiTLE on scalp EEG.
LoPinto-Khoury et al. 100 found no significant differences in Engel class I surgical outcomes of PET-positive and MRI-negative TLE patients who were implanted prior to resection versus those who went directly to surgery, although it is noted that this was a retrospective study, and they had employed very stringent selection criteria when choosing MRI-negative TLE candidates for surgery. Based on the excellent reported surgical outcomes of MRI-negative TLE patients with concordant FDG-PET and electroclinical findings (interictal and ictal EEG maximal at FT9/ 10, F9/10, F7/8, or SP1/SP2 with consistent semiology), our Potential algorithm for presurgical evaluation of pharmacoresistant MRI-negative TLE. Epilepsia ILAE institution has elected to perform confirmatory intraoperative mesial temporal depth electrode recordings with neocortical ECoG, and then implanting chronic intracranial electrodes for ICEEG monitoring only if there is evidence for lateral temporal or extratemporal epileptiform disturbances of cerebral activity. Based on the evidence of the studies presented, a potential algorithm for the presurgical evaluation of MRI-negative TLE is shown (Fig. 3) .
Large-scale multicenter studies in MRI-negative TLE remain to be conducted, as further characterization of this group will improve our understanding of the pathophysiology and natural history of its different subtypes.
